Financial Data and Key Metrics Changes - For Q1 2025, the company reported revenues of $600,000, primarily driven by sales in the industrial verticals [23] - R&D and SG&A expenses for Q1 2025 were $14.1 million, including $1.9 million in non-cash charges related to stock-based compensation and $1.4 million in non-cash charges related to depreciation and amortization, resulting in a reduction of 45% year-over-year [24][25] - The company finished the quarter with $69 million in cash and cash equivalents, with additional availability under various facilities [26][27] Business Line Data and Key Metrics Changes - The automotive segment is engaged in seven RFQs, but progress has been slow due to OEMs focusing on supply chain issues and tariff impacts [7][19] - The industrial segment is seeing momentum, particularly in AGV and AMR applications, with expectations for commercial wins from ongoing evaluations [12][20] - The defense vertical is expanding, with a focus on partnerships and leveraging existing technology for military applications [14][22] Market Data and Key Metrics Changes - The automotive industry is navigating a complex landscape influenced by tariffs, leading to a focus on component costs and the origin of systems [19] - The industrial market is experiencing increased demand for automation and AI, with the company well-positioned to meet this demand [20][21] - The defense market presents multiple opportunities for technology application, including drones and unmanned vehicles, which differ significantly from automotive applications [106] Company Strategy and Development Direction - The company aims to strengthen its balance sheet and focus on custom development opportunities with OEMs in the automotive sector [11] - There is a strategic push towards the defense sector, with plans to engage with the Department of Defense and explore partnerships with larger companies [14][22] - The company is preparing for an Investor Day to showcase technology offerings and engage with potential customers [15] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the slow progress in automotive RFQs but remains optimistic about the long-term potential in this segment [11] - The company expects to generate $30 million to $50 million in revenue over the next 12 to 18 months, primarily from industrial engagements [28] - Management emphasizes the importance of patience and strategic engagement with customers to ensure sustainable growth [78] Other Important Information - The company has secured a production commitment with ZF in France, minimizing exposure to China tariffs and enhancing competitiveness [18] - The company plans to expand production capacity later in the year based on customer agreements [55] Q&A Session Summary Question: Is this the first quarter with commercial sales? - No, commercial sales were also present in Q4 [32] Question: What is driving the potential $30 million to $50 million revenue range? - Primarily driven by industrial automation and ADAS deployment [36][38] Question: How many unique entities is the company working with? - Less than 10 [45] Question: What is the scope of military opportunities? - The company is not a prime contractor but aims to be a technology partner for primes [46][47] Question: How does the company plan to compete with existing players in the industrial vertical? - By offering integrated solutions with software and achieving economies of scale [81][83] Question: What are the 2025 milestones to track? - Focus on signing commercial deals in industrial, engaging in pilot programs in defense, and developing partnerships in automotive [92][93]

Peraso (PRSO) Q1 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants James Sullivan - Chief Financial OfficerRonald Glibbery - Co-Founder, CEO & DirectorKevin Liu - Founder & CEO Conference Call Participants David Williams - Equity Research Analyst Operator Good afternoon. Welcome to Puraso, Inc. First Quarter twenty twenty five Conference Call. At this time, all participants are in a listen only mode. As a reminder, this conference call is being I would now like to turn the call over to your h ...

Financial Data and Key Metrics Changes - Total revenue for Q1 2025 was $7,200,000, a 3% decrease from $7,300,000 in the prior year due to delayed deliveries [25][26] - Gross profit improved to $5,200,000, representing 73% of total revenue compared to 64% in the prior year, reflecting a 25% decrease in cost of sales [26] - Operating income increased 110% to $1,400,000 compared to $650,000 in the prior year [27] - Net income for the quarter was $1,300,000 or $0.11 per diluted share, a 170% increase from $470,000 or $0.04 per diluted share in Q1 2024 [27] - Adjusted EBITDA increased 22% to $1,700,000 compared to $1,400,000 in the prior year [27] - Cash and cash equivalents totaled $17,600,000 as of March 31, down from $18,000,000 at year-end [27] Business Line Data and Key Metrics Changes - Government revenue for Q1 was $5,200,000, down from $6,700,000 in the prior year, while international revenue increased to $1,900,000 from $550,000 [25][26] - Bookings for the quarter totaled $6,400,000, more than double the $2,900,000 reported in Q1 2024 [28] - Backlog as of March 31, 2025, stood at $21,200,000, segmented into $9,900,000 in capital, $5,800,000 in service, and $5,500,000 in STEP contracts [29] Market Data and Key Metrics Changes - The company noted that sales cycles are taking longer due to funding being held back during internal reviews and leadership transitions [6] - Interest in flexible purchasing pathways, including subscription-based models, is increasing among agencies [7] Company Strategy and Development Direction - The company is focusing on operational execution and adapting to economic uncertainties while reinforcing its role as a trusted training partner [5] - Strategic actions include early coordination with agencies during budgeting processes and aligning offerings with agency needs [9] - The company is enhancing its marketing function and digital strategy to improve lead capture and engagement [12][14] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing macro headwinds affecting customer decisions but emphasized the importance of training mandates [5][6] - The company is confident in its ability to convert backlog into revenue and support scalable growth despite funding constraints [24][30] Other Important Information - The VXR extended reality platform is generating interest, with two units sold and more in discussions [15][16] - The company is expanding its certified training content, now offering over 120 hours of certified courses [19] Q&A Session Summary Question: Did macro dynamics contribute to any orders being pulled into Q1? - Management indicated that it was unclear if macro dynamics influenced order timing, noting that some agencies were trying to spend budgeted funds before potential shutdowns [34][35] Question: Is there demand for VXR from other market verticals? - Management confirmed that grant activity is driving demand for VXR, with interest from adjacent markets like healthcare and private security [36] Question: Are customers being forced into three-year agreements for the STEP program? - Management clarified that while customers are encouraged to move to three-year agreements, it is not strictly enforced, but it is a tactic to advance the sales cycle [38][39][41]

Vuzix (VUZI) Q1 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants Edward McGregor - Director of Investor RelationsPaul Travers - CEO, President & DirectorGrant Russell - CFO, EVP, Treasurer & Director Conference Call Participants Christian Schwab - Senior Research Analyst Operator Greetings, and welcome to the Vuzix First Quarter Ending 03/31/2025 Financial Results and Business Update Conference Call. At this time, all participants are in a listen only mode. A brief question and answer sessio ...

Regenxbio (RGNX) Q1 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants Patrick Christmas II - Chief Legal OfficerCurran Simpson - Board Member, President & CEOSteve Pakola - Chief Medical OfficerMitchell Chan - CFOMani Foroohar - Senior Managing DirectorGena Wang - MD - Biotech Equity ResearchTejas Wein - Associate Director - Biotechnology Equity ResearchAnnabel Samimy - Managing DirectorShelby Hill - Biotech Equity Research AssociateSean McCutcheon - Vice President - Biotechnology Equity Rese ...

Assertio (ASRT) Q1 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants Matthew Kreps - Managing DirectorBrendan O’Grady - CEORaghuram Selvaraju - Managing Director, Healthcare Equity Research Conference Call Participants Thomas Flaten - Senior Research AnalystNaz Rahman - AnalystScott Henry - Managing Director & Senior Research AnalystJim Sidoti - Analyst Operator Good day, ladies and gentlemen. Welcome to the Associal Holdings First Quarter twenty twenty five Results Conference Call. Just a re ...

Vicarious Surgical (RBOT) Q1 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants Webb Campbell - Vice PresidentAdam Sachs - Co-Founder & CEOSarah Romano - CFOEric Anderson - Vice President Equity Research Conference Call Participants None - Analyst Operator Hello, everyone, and welcome to the Vicarius Surgical twenty twenty five First Quarter Earnings Call. My name is Nadia, and I'll be coordinating the call today. Will now hand over to your host, Webb Campbell, Investor Relations, to begin. We ...

Relmada Therapeutics (RLMD) Q1 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants Brian Ritchie - Managing DirectorSergio Traversa - CEO & Member of Board of DirectorsMaged Shenouda - Chief Financial OfficerUy Ear - Vice PresidentYair Lotan - Professor of Urology & Chief of Urologic OncologyMatthew Barcus - Senior Research Associate Operator Good afternoon. Welcome to Ramada Therapeutics First Quarter twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. A ...

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was reported at $329 million, reflecting a 20% year-on-year increase [5][12] - Resident count increased by 15% year-on-year, reaching approximately 189,000 [5][12] - Adjusted EBITDA for the quarter was $23.4 million, a 16% increase compared to the previous year [5][12] - Excluding PUBCO costs, adjusted EBITDA growth was 20% year-on-year [12] Business Line Data and Key Metrics Changes - The growth in revenue was driven by organic growth and acquisitions, specifically from Heartland and Freedom pharmacies [12] - Gross profit increased by 17% to $64.4 million [12] Market Data and Key Metrics Changes - The company is actively monitoring industry trends, particularly the impact of tariffs and the Inflation Reduction Act [9][10][11] Company Strategy and Development Direction - The company is focused on sustainable long-term value for shareholders and has a robust acquisition pipeline with several near-term opportunities [5][6] - Recent acquisition of a small pharmacy in Wichita, Kansas, increased the total number of pharmacies to 52 [6] - The company is committed to integrating acquisitions effectively, with a playbook designed to transition acquired pharmacies to its operating model over three to four years [7][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating potential impacts from the Inflation Reduction Act and tariffs, indicating a strong position to avoid major disruptions [10][11] - The company expects to end the year in the upper half of its revenue guidance range due to strong Q1 performance [5][16] Other Important Information - The company ended Q1 with $14 million in cash and zero debt, indicating a strong financial position [16] - Adjusted EBITDA guidance for the year remains between $97 million and $101 million, with a conservative approach due to integration-related expenses [17] Q&A Session Summary Question: Size of Heartland drag in Q1 and full year integration costs - Management indicated that integration costs were included in guidance, with approximately $500,000 pulled into Q1 due to expedited operating system conversion [24][26] Question: Impact of Trump executive order on payer negotiations - Management noted uncertainty regarding the executive order's effects but remains positive about ongoing discussions with payors [27][28] Question: Breakdown of resident count growth between same-store metrics and acquisitions - Management confirmed that organic growth met guidance expectations, with the remainder attributed to acquisitions [38] Question: Pipeline status and impact of economic uncertainty - Management reported a robust acquisition pipeline, indicating that economic pressures have not negatively impacted opportunities [40]

Financial Data and Key Metrics Changes - The company reported total organic growth of 6% in Q1, at the top end of previous guidance [6] - Adjusted EBITDA was $215 million with a margin of 17.2%, exceeding the high end of Q1 guidance due to strong execution [7] - Earnings per share (EPS) was $1.62, reflecting benefits from share repurchases and a planned increase in the tax rate [7] - Free cash flow conversion was 40%, highlighting progress on accounts receivable collections [7] Business Line Data and Key Metrics Changes - ATM Managed Services and Digital Retail Solutions (AMS DRS) grew over 20% for the fourth consecutive quarter, now representing a quarter of total business [6][8] - Cash and Valuables Management (CVM) grew 1% organically, with strong performance in Global Services contributing to overall growth [18] - The Global Services business saw elevated precious metal movement, leading to improved year-over-year growth [8] Market Data and Key Metrics Changes - North America experienced constant currency growth of 4% and organic growth of 2%, with DRS growth highlighted by new customer onboarding [13] - Latin America reported 7% organic growth, but this was offset by currency devaluation, particularly in Mexico and Argentina [14] - Europe grew revenue by 5% organically, with AMS DRS mix increasing to 42% of total revenue [15] Company Strategy and Development Direction - The company is focused on maximizing growth potential in AMS DRS, expanding margins, and executing a capital allocation framework [7][10] - The strategy includes increasing network density and improving routing flexibility to support profit margin expansion [25] - The company is exploring accretive M&A opportunities that align with its capital allocation framework [31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's resilience amid economic uncertainty, citing a diversified global footprint and strong customer relationships [24][25] - The outlook for the second quarter includes expectations for continued mid-single-digit organic growth and EBITDA between $200 million and $225 million [10][34] - Management remains cautious about the Global Services business due to slowing growth trends observed in early Q2 [19] Other Important Information - The company repurchased 1.3 million shares at an average price of $87.62, representing about 3% of outstanding shares [9] - A third consecutive annual increase in the quarterly dividend was announced, reflecting a commitment to shareholder returns [9][31] Q&A Session Summary Question: Can you talk about your tariff exposure? - Management indicated no significant direct exposure to tariffs, as most costs and revenues are in the same currency and services are not heavily imported [39][40] Question: Can you discuss pricing trends in Latin America? - Management confirmed that pricing strategies are in place to offset currency devaluations, particularly in highly inflationary markets like Argentina [42][43] Question: What are the drivers for the second quarter margin guidance? - Key drivers include FX impacts, interest income from Argentina, and restructuring actions, with expectations for improved margins in the second half of the year [50][51][55] Question: What is the expected impact of interest income on EBITDA for the full year? - Management expects a headwind of approximately $4 million to $5 million per quarter from reduced interest income [56] Question: What are the growth expectations excluding last year's equipment sales? - Management anticipates continued growth trajectory in DRS AMS, despite a couple of points of headwind from last year's equipment sales [62][63] Question: Why is AMS DRS expected to be more resilient to macro softness? - The larger white space and subscription-based revenue model of AMS DRS provide more consistent revenues compared to traditional CIT business [70][71]